-
Je něco špatně v tomto záznamu ?
Ongoing evolution of Chlamydia trachomatis lymphogranuloma venereum: exploring the genomic diversity of circulating strains
HMB. Seth-Smith, A. Bénard, SM. Bruisten, B. Versteeg, B. Herrmann, J. Kok, I. Carter, O. Peuchant, C. Bébéar, DA. Lewis, T. Puerta, D. Keše, E. Balla, H. Zákoucká, F. Rob, SA. Morré, B. de Barbeyrac, JC. Galán, HJC. de Vries, NR. Thomson, D....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2016
Free Medical Journals
od 2015
Freely Accessible Science Journals
od 2015-07-01
PubMed Central
od 2015
Europe PubMed Central
od 2015
ROAD: Directory of Open Access Scholarly Resources
od 2015
PubMed
34184981
DOI
10.1099/mgen.0.000599
Knihovny.cz E-zdroje
- MeSH
- Chlamydia trachomatis klasifikace genetika MeSH
- dospělí MeSH
- fylogeneze MeSH
- genomika * MeSH
- genotyp MeSH
- homosexualita mužská MeSH
- lidé středního věku MeSH
- lidé MeSH
- lymphogranuloma venereum epidemiologie mikrobiologie MeSH
- mladý dospělý MeSH
- molekulární epidemiologie * MeSH
- molekulární evoluce * MeSH
- proteiny vnější bakteriální membrány genetika MeSH
- sekvence nukleotidů MeSH
- sekvenční analýza MeSH
- sekvenování celého genomu MeSH
- senioři MeSH
- sexuálně přenosné nemoci mikrobiologie MeSH
- sexuální a genderové menšiny MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Austrálie MeSH
- Evropa MeSH
Lymphogranuloma venereum (LGV), the invasive infection of the sexually transmissible infection (STI) Chlamydia trachomatis, is caused by strains from the LGV biovar, most commonly represented by ompA-genotypes L2b and L2. We investigated the diversity in LGV samples across an international collection over seven years using typing and genome sequencing. LGV-positive samples (n=321) from eight countries collected between 2011 and 2017 (Spain n=97, Netherlands n=67, Switzerland n=64, Australia n=53, Sweden n=37, Hungary n=31, Czechia n=30, Slovenia n=10) were genotyped for pmpH and ompA variants. All were found to contain the 9 bp insertion in the pmpH gene, previously associated with ompA-genotype L2b. However, analysis of the ompA gene shows ompA-genotype L2b (n=83), ompA-genotype L2 (n=180) and several variants of these (n=52; 12 variant types), as well as other/mixed ompA-genotypes (n=6). To elucidate the genomic diversity, whole genome sequencing (WGS) was performed from selected samples using SureSelect target enrichment, resulting in 42 genomes, covering a diversity of ompA-genotypes and representing most of the countries sampled. A phylogeny of these data clearly shows that these ompA-genotypes derive from an ompA-genotype L2b ancestor, carrying up to eight SNPs per isolate. SNPs within ompA are overrepresented among genomic changes in these samples, each of which results in an amino acid change in the variable domains of OmpA (major outer membrane protein, MOMP). A reversion to ompA-genotype L2 with the L2b genomic backbone is commonly seen. The wide diversity of ompA-genotypes found in these recent LGV samples indicates that this gene is under immunological selection. Our results suggest that the ompA-genotype L2b genomic backbone is the dominant strain circulating and evolving particularly in men who have sex with men (MSM) populations.
Applied Microbiology Research Department of Biomedicine University of Basel Basel Switzerland
Bacterial STI Reference Laboratory National Public Health Center Budapest Hungary
Clinical Bacteriology and Mycology University Hospital Basel University of Basel Switzerland
Clinical Research Department London School of Hygiene and Tropical Medicine London UK
Department of Infectious Diseases GGD Public Health Service of Amsterdam Amsterdam The Netherlands
Section of Clinical Bacteriology Department of Medical Sciences Uppsala University Uppsala Sweden
SIB Swiss Institute of Bioinformatics Basel Switzerland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004278
- 003
- CZ-PrNML
- 005
- 20220127145401.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1099/mgen.0.000599 $2 doi
- 035 __
- $a (PubMed)34184981
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Seth-Smith, Helena M B $u Clinical Bacteriology & Mycology, University Hospital Basel, University of Basel, Switzerland $u Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland $u SIB Swiss Institute of Bioinformatics, Basel, Switzerland
- 245 10
- $a Ongoing evolution of Chlamydia trachomatis lymphogranuloma venereum: exploring the genomic diversity of circulating strains / $c HMB. Seth-Smith, A. Bénard, SM. Bruisten, B. Versteeg, B. Herrmann, J. Kok, I. Carter, O. Peuchant, C. Bébéar, DA. Lewis, T. Puerta, D. Keše, E. Balla, H. Zákoucká, F. Rob, SA. Morré, B. de Barbeyrac, JC. Galán, HJC. de Vries, NR. Thomson, D. Goldenberger, A. Egli
- 520 9_
- $a Lymphogranuloma venereum (LGV), the invasive infection of the sexually transmissible infection (STI) Chlamydia trachomatis, is caused by strains from the LGV biovar, most commonly represented by ompA-genotypes L2b and L2. We investigated the diversity in LGV samples across an international collection over seven years using typing and genome sequencing. LGV-positive samples (n=321) from eight countries collected between 2011 and 2017 (Spain n=97, Netherlands n=67, Switzerland n=64, Australia n=53, Sweden n=37, Hungary n=31, Czechia n=30, Slovenia n=10) were genotyped for pmpH and ompA variants. All were found to contain the 9 bp insertion in the pmpH gene, previously associated with ompA-genotype L2b. However, analysis of the ompA gene shows ompA-genotype L2b (n=83), ompA-genotype L2 (n=180) and several variants of these (n=52; 12 variant types), as well as other/mixed ompA-genotypes (n=6). To elucidate the genomic diversity, whole genome sequencing (WGS) was performed from selected samples using SureSelect target enrichment, resulting in 42 genomes, covering a diversity of ompA-genotypes and representing most of the countries sampled. A phylogeny of these data clearly shows that these ompA-genotypes derive from an ompA-genotype L2b ancestor, carrying up to eight SNPs per isolate. SNPs within ompA are overrepresented among genomic changes in these samples, each of which results in an amino acid change in the variable domains of OmpA (major outer membrane protein, MOMP). A reversion to ompA-genotype L2 with the L2b genomic backbone is commonly seen. The wide diversity of ompA-genotypes found in these recent LGV samples indicates that this gene is under immunological selection. Our results suggest that the ompA-genotype L2b genomic backbone is the dominant strain circulating and evolving particularly in men who have sex with men (MSM) populations.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a proteiny vnější bakteriální membrány $x genetika $7 D001425
- 650 _2
- $a sekvence nukleotidů $7 D001483
- 650 _2
- $a Chlamydia trachomatis $x klasifikace $x genetika $7 D002692
- 650 12
- $a molekulární evoluce $7 D019143
- 650 12
- $a genomika $7 D023281
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a homosexualita mužská $7 D018451
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lymphogranuloma venereum $x epidemiologie $x mikrobiologie $7 D008219
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a molekulární epidemiologie $7 D017720
- 650 _2
- $a fylogeneze $7 D010802
- 650 _2
- $a sekvenční analýza $7 D017421
- 650 _2
- $a sexuální a genderové menšiny $7 D000072339
- 650 _2
- $a sexuálně přenosné nemoci $x mikrobiologie $7 D012749
- 650 _2
- $a sekvenování celého genomu $7 D000073336
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Austrálie $x epidemiologie $7 D001315
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bénard, Angèle $u Present address: Healthcare Systems Research Group, VHIR, Universitat Autònoma de Barcelona, Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain $u Wellcome Trust Sanger Institute, Cambridge, UK
- 700 1_
- $a Bruisten, Sylvia M $u Department of Infectious Diseases, GGD Public Health Service of Amsterdam, Amsterdam, The Netherlands $u Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity (AII), Location Academic Medical Centre, Amsterdam, The Netherlands
- 700 1_
- $a Versteeg, Bart $u Department of Infectious Diseases, GGD Public Health Service of Amsterdam, Amsterdam, The Netherlands $u Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK
- 700 1_
- $a Herrmann, Björn $u Section of Clinical Bacteriology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden
- 700 1_
- $a Kok, Jen $u Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales, Australia $u Marie Bashir Institute for Infectious Diseases and Biosecurity & Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia
- 700 1_
- $a Carter, Ian $u Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales, Australia
- 700 1_
- $a Peuchant, Olivia $u CHU Bordeaux, Department of Bacteriology, French National Reference Center for bacterial STIs, Bordeaux, France
- 700 1_
- $a Bébéar, Cécile $u CHU Bordeaux, Department of Bacteriology, French National Reference Center for bacterial STIs, Bordeaux, France
- 700 1_
- $a Lewis, David A $u Western Sydney Sexual Health Centre, Western Sydney Local Health District, Parramatta, New South Wales, Australia $u Marie Bashir Institute for Infectious Diseases and Biosecurity & Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia
- 700 1_
- $a Puerta, Teresa $u Unidad de ITS/VIH, Centro Sanitario Sandoval, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain
- 700 1_
- $a Keše, Darja $u University of Ljubljana, Faculty of Medicine, Institute of Microbiology and Immunology, Ljubljana, Slovenia
- 700 1_
- $a Balla, Eszter $u Bacterial STI Reference Laboratory, National Public Health Center (former National Center for Epidemiology), Budapest, Hungary
- 700 1_
- $a Zákoucká, Hana $u National Reference Laboratory for Diagnostics of Syphilis and Chlamydia Infections, National Institute of Public Health, Srobarova 48, 100 42, Prague 10, Czech Republic
- 700 1_
- $a Rob, Filip $u Department of Dermatovenereology, Second Faculty of Medicine, Charles University and Hospital Bulovka, Budinova 2, 180 81, Prague 8, Czech Republic
- 700 1_
- $a Morré, Servaas A $u Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center Amsterdam, Amsterdam, The Netherlands $u Institute for Public Health Genomics (IPHG), Department of Genetics and Cell Biology, Research Institute GROW, University of Maastricht, Maastricht, The Netherlands
- 700 1_
- $a de Barbeyrac, Bertille $u CHU Bordeaux, Department of Bacteriology, French National Reference Center for bacterial STIs, Bordeaux, France
- 700 1_
- $a Galán, Juan Carlos $u Servicio de Microbiología, Hospital Universitario Ramón y Cajal. Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. CIBER en Epidemiología y Salud Pública (CIBERESP)
- 700 1_
- $a de Vries, Henry J C $u Department of Infectious Diseases, GGD Public Health Service of Amsterdam, Amsterdam, The Netherlands $u Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity (AII), Location Academic Medical Centre, Amsterdam, The Netherlands
- 700 1_
- $a Thomson, Nicholas R $u Wellcome Trust Sanger Institute, Cambridge, UK $u Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK
- 700 1_
- $a Goldenberger, Daniel $u Clinical Bacteriology & Mycology, University Hospital Basel, University of Basel, Switzerland
- 700 1_
- $a Egli, Adrian $u Clinical Bacteriology & Mycology, University Hospital Basel, University of Basel, Switzerland $u Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland
- 773 0_
- $w MED00208694 $t Microbial genomics $x 2057-5858 $g Roč. 7, č. 6 (2021)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34184981 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145357 $b ABA008
- 999 __
- $a ok $b bmc $g 1751674 $s 1155427
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 7 $c 6 $e - $i 2057-5858 $m Microbial genomics $n Microb Genom $x MED00208694
- LZP __
- $a Pubmed-20220113